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Abstract
We report a case of two pseudolymphomas of the liver 
in a 63-year-old Japanese woman with primary biliary 
cirrhosis. One of the lesions was found incidentally 
during a medical examination, presenting as a 10 
mm hypodense nodule that revealed hyperdensity in 
the early phase and hypodensity in the late phase in 
computed tomography (CT) after injection of contrast 
medium. Retrospectively, the 10 mm nodule had first 
been discovered as a 4 mm nodule during CT 4 years 
previously. Superparamagnetic iron oxide-enhanced 
MRI revealed another 4 mm hyperintense nodule in 
segment 6 in addition to the 10 mm hyperintense nodule 
in segment 7. CT during arterial portography revealed 
two hypointense nodules. Findings with other imaging 
modalities such as ultrasonography, magnetic resonance 
imaging, and hepatic angiography were consistent 
with hepatocellular carcinoma. A right posterior 
segmentectomy was performed, and the lesions were 
microscopically diagnosed as pseudolymphoma. To 
the best of our knowledge, only 31 other cases of 
this disease have ever been reported, with a highly 
asymmetrical male:female ratio of 1:9.7. Although we 
could find only one case of transformation of hepatic 
pseudolymphoma into lymphoma in the liver, the exact 
nature of development from benign pseudolymphoma 
to malignant lymphoma is still not fully understood and 
cases of hepatic lymphoma need to be followed carefully.
© 2009 The WJG Press and Baishideng. All rights reserved.
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INTRODUCTION
Pseudolymphoma in the liver is an extremely rare disease. 
Although the exact etiology remains unknown, it is 
speculated that the disorder is a reactive immunological 
response to a chronic infection or inflammation[1]; 
hepatic pseudolymphoma can develop in patients with 
autoimmune diseases[2,3], malignancy[4], or hepatitis[5] or 
who are administered interferon therapy[6]. It has been 
reported that diagnosis of  pseudolymphoma is difficult 
without histopathological examination, since image 
findings are quite similar to hepatocellular carcinoma 
(HCC)[2]. Although pseudolymphoma is generally thought 
to be benign, the risk of  malignant transformation into 
lymphoma remains controversial. 
We report a case of  hepatic pseudolymphoma in a 
female Japanese patient with primary biliary cirrhosis 
(PBC) and discuss the literature.
CASE REPORT
A 63-year-old female with a history of  PBC and resection 
of  the left adrenal gland for primary aldosteronism, 
was admitted to our hospital for further evaluation of  
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a hepatic lesion incidentally discovered in abdominal 
computed tomography (CT). The patient had taken only 
ursodeoxycholic acid 300 mg/d for PBC for 10 years and 
had not taken immunosuppressive agents. The patient 
was asymptomatic on admission and her condition was 
generally good. She had a surgical scar on her abdomen. 
We noted no hepatospenomegaly, lymphadenopathy, or 
peripheral edema. Laboratory tests showed a prothrombin 
time of  11.8 s (normal, 10.8-13.3), a total bilirubin 
level of  0.6 mg/dL (normal, 0.3-1.2), and an albumin 
level of  4.0 g/dL (normal, 4.0-5.0). Her serum alkaline 
phosphatase level was 350 IU/L (normal, 115-359), 
γ-glutamyltransferase 48 IU/L (normal, 10-47), aspartate 
aminotransferase 24 IU/L (normal, 13-33), and alanine 
aminotransferase 16 IU/L (normal, 6-27). Serology 
examinations for hepatitis B and C viruses were negative. 
Rheumatoid factor antibodies, Sjögren syndrome-A 
antibodies, and Sjögren syndrome-B antibodies were 
negative. Antinuclear antibodies and antimitochondrial 
an t ibod ie s were pos i t ive . Immunog lobu l in G, 
immunoglobulin M, and immunoglobulin A were within 
normal ranges. Alpha-fetoprotein, protein induced by 
vitamin K absence, and carcinoembryonic antigen were 
within normal ranges. A urea breath test was negative. 
Abdominal ultrasonography showed a hypoechoic lesion, 
10 mm in diameter in segment 7 (data not shown). CT 
demonstrated a 10 mm hypodense nodule that revealed 
hyperdensity in the early phase and hypodensity in the 
late phase after injection of  contrast medium (Figure 1). 
Retrospectively, this nodule had previously shown up as 
a 4 mm nodule in a CT performed for examination of  
an adrenal tumor 4 years previously (data not shown). 
Magnetic resonance imaging (MRI) showed a hypointense 
nodule on T1-weighted images and a hyperintense nodule 
on T2-weighted images in segment 7. Following injection 
of  contrast MRI, a hyperintense nodule in the arterial 
phase and a hypointense nodule in the portal phase 
were revealed (Figure 2). Superparamagnetic iron oxide-
www.wjgnet.com
Figure 1  Computed tomography (CT) showing 
a 10 mm nodule in segment 7. A: A hypodense 
nodule in plane phase; B: A hyperdense nodule in 
the early phase after injection of contrast medium; 
C: A hypodense nodule in the late phase after 
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Figure 2  Magnetic resonance imaging (MRI) 
showing a 10 mm nodule in segment 7. A: A 
hypointense nodule on T1-weighted images; B: 
A hyperintense nodule on T2-weighted images; 
C: A hyperintense nodule in the early phase after 
injection of contrast medium; D: A hypointense 






enhanced MRI revealed another 4 mm hyperintense 
nodule in segment 6 in addition to the 10 mm hyperintense 
nodule in segment 7 (Figure 3). Although angiography 
via the common hepatic artery did not demonstrate 
tumor staining, CT during arterial portography revealed 
two hypointense nodules (Figure 4). Imaging findings 
suggested HCC, although no other hypervascular tumor 
could be excluded. The patient received an explanation 
of  the results, including the possibility of  a benign 
tumor, and expressed a desire for surgical extraction 
of  the nodules. A right posterior segmentectomy was 
performed. Macroscopically, the lesion in segment 7 was 
white and hard with clear margins (Figure 5A) and the 
lesion in segment 6 was not detected. Microscopically, two 
lesions showed similar histological features. The lesions 
exhibited a nodular infiltration of  mature small lymphoid 
cells with many lymph follicles. No obvious atypical cells 
were identified in both lesions. Bile ducts were identified 
at the periphery of  the lesions, although characteristic 
lymphoepithelial lesions could not be identified. No 
necrosis or granulomatous inflammation was identified 
(Figure 5B). Pseudolymphoma and extranodal marginal 
www.wjgnet.com
Figure 3  Superparamagnetic iron oxide-
enhanced MRI showing hyperintense nodules. 





Figure 4  CT during arterial portography 
showing hypointense nodules. A: 10 mm nodule 




Figure 5  The pathological findings of the lesions. A: Macroscopically, the lesion was white and hard with a clear margin (a lesion in segment 7); B: Microscopically, 
the lesion consisted of a nodular lymphoid infiltrate with germinal centers (a lesion in segment 7), HE stain (× 40); Lymphocytes in the lesions consisted of CD3-
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zone B-cell lymphoma (MALToma) were differential 
diagnosis. Then, we performed immunohistochemical 
analysis and in situ hybridization. Immunostainings for 
CD3, CD20, and CD79 revealed regularly distributed T 
cells and B cells (Figure 5C and D). Plasma cells were not 
many in number in the lesions, but in situ hybridization for 
immunoglobulin light chains was performed because it is 
one of  the useful tools to discriminate between reactive 
lymphoid lesions and MALToma. In situ hybridization 
revealed no significant difference between the numbers of  
cells positive for kappa-chain and lambda-chain (Figure 
5E and F). Based on these histological features, the lesions 
were diagnosed as pseudolymphoma. 
In the background liver, liver parenchyma showed 
bridging fibrosis with lymphoid infiltrate in portal tracts. 
Granulomas cholangitis and ductopenia were identified. 
Those histological features were consistent with Stage 
2 PBC. The patient had an uneventful postoperative 
course and has shown no sign of  recurrence for 11 mo.
DISCUSSION
In the liver, pseudolymphoma has also been variously 
termed as reactive lymphoid hyperplasia and nodular 
lymphoid lesion, and shows histological features of  
hyperplastic lymphoid follicles with polymorphic and 
polyclonal cell populations composed of  small mature 
lymphocytes, mature plasma cells, macrophages, stroma 
fibrosis and often numerous germinal centers. It is 
usually localized and well demarcated from surrounding 
tissue[1]. Pseudolymphoma may occur at numerous sites 
including the stomach[7], lung[8], ocular adnexa[9], hard 
palate and oral mucosa[10], skin[11], and breast[12].
To the best of  our knowledge, 32 cases (including 
ours) of  hepatic pseudolymphoma have been reported 
in the English and Japanese literature (Table 1). There 
was a strongly asymmetric male-to-female ratio of  1:9.7 
(3 M/29 F). While other sites of  pseudolymphoma 
also tended to show asymmetry, only pseudolymphoma 
of  the breast approached that of  the liver in terms of  
asymmetry magnitude. All seven reported cases of  
breast pseudolymphoma were female[12], but breast 
examination is limited almost exclusively to females, 
which could bias these findings. Reported male-female 
ratios of  pseudolymphoma of  the hard palate and oral 
mucosa[10], lung[8], and skin[11] were 1:2.8, 1:1.2 and 1:1.8, 
respectively, while ocular adnexal lymphoid hyperplasia 
affects men and women about equally[9]. Thus the 
extreme female asymmetry of  hepatic pseudolymphoma 
is a unique characteristic.
Eight of  32 cases of  hepatic lymphoma were 
associated with autoimmune disease and eight with 
malignant tumor (Table 1). In the lung, cases of  
pseudolymphoma associated with autoimmune disorders 
www.wjgnet.com
Table 1  Reported cases of hepatic pseudolymphoma
No. Author (reference) Age Sex No. Size (cm) Pathological diagnosis Association
  1 Snover et al[32] 15 F 1 PL Combined immunodeficiency, liver fibrosis
  2 Grouls et al[1] 85 F 2 1.4, 0.8 PL Gastric cancer
  3 Tanabe et al[33] 30 F 1 1.5 PL Acute enteritis
  4 Isobe et al[34] 59 F 1 0.9 RLH Diabetes mellitus
  5 Ohtsu et al[6] 42 F 1 1.5 PL Chronic hepatitis B, interferon-α therapy
  6 Katayanagi et al[35] 66 F 2 1.5, 1.0 PL Diabetes mellitus
  7 Tanizawa et al[36] 67 F 1 2 RLH Abnormal liver function
  8 Endo et al[37] 38 F 1 1.8 PL Pancytopenia
  9 Kim et al[5] 72 M 1 1.7 PL Chronic hepatitis C, gastric cancer
10 Fujinaga et al[38] 58 F 1 1.5 PL Hypertension
11 Nishijima et al[39] 58 F 1 1.2 PL Hypertension, diabetes mellitus
12 Sharifi et al[3] 52 F 1 0.4 NLL Primary biliary cirrhosis
13 56 F 1 1.5 NLL Primary biliary cirrhosis, CREST syndrome
14 56 M 1 0.7 NLL Diverticulitis
15 Nagano et al[40] 47 F 1 1.7 RLH Chronic thyroiditis, high titer of ANA
16 Pantanowitz et al[41] 69 F 2 1.7, 1.0 RLH Renal cell carcinoma
17 Okubo et al[2] 49 F 1 2 PL Sjögren's syndrome
18 Mori et al[42] 49 F 1 1.8 PL Chronic hepatitis B
19 Okuhama et al[43] 70 M 1 4 PL
20 Shiozawa et al[44] 51 F 1 2 PL
21 Takahashi et al[45] 77 F 1 1.5 RLH Colon cancer
22 64 F 2 0.9, 0.7 RLH Colon cancer
23 Maehara et al[46] 72 F 2 1.3, 1.0 RLH
24 Willenbrock et al[47] 36 F 1 1.8 NLL Ovarian cyst, focal nodular hyperplasia of the liver
25 Sato et al[4] 75 F 1 1.4 RLH Gastric cancer, colon cancers, metastatic liver tumor
27 Ota et al[20] 63 F 1 1.6 PL Gastric ulcer, Helicobacter pylori infection
28 Machida et al[48] 53 F 3 1.5, 1.2, 1.0 RLH Autoimmune thyroiditis
29 Matsumoto et al[49] 67 F 1 1.5 PL Hypertension
30 Jiménez et al[50] 34 F 1 2.3 NLH Hypothyroidism
31 Park et al[51] 46 F 2 1.0, 1.0 RLH Renal cell carcinoma
32 Present case 63 F 2 1.3, 0,4 PL Primary biliary cirrhosis, primary aldosteronism
RLH: Reactive lymphoid hyperplasia; PL: Pseudolymphoma; NLL: Nodular lymphoid lesion; NLH: Nodular lymphoid hyperplasia; CREST: Calcinosis, 
Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia; ANA: Antinuclear antibody.
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such as Sjögren’s disease were reported[13], which is similar 
to the liver. In other organs, several factors are thought 
to be associated with pseudolymphoma, i.e. Epstein-
Barr virus (hard palate and oral mucosa[14]), mechanical 
stimulation (ear[15]), anticonvulsant drugs (skin[16]) and 
Helicobacter pylori (H pylori) (stomach[17,18]). Regarding the 
association of H pylori with gastric pseudolymphoma, 
successful treatment of  the pseudolymphoma by 
eradication of  H pylori has been reported[19]. Ota et al[20] 
reported a case of  hepatic pseudolymphoma in which the 
diameter decreased after H pylori eradication. In the case 
reported here, the patient had no H pylori infection.
Transformation of  pseudolymphoma to lymphoma 
has been discussed. Malignant transformation of  
pseudolymphomas in the lung[21] and stomach[22] have 
been reported. These reports, however, either predated 
or did not include the use of  immunofluorescent 
techniques. It is likely that these cases were in fact the 
early stage of  primary lymphoma misinterpreted as 
benign[8]. On the other hand, evidence of  progression 
from histologically benign, immunohistochemically 
polyclonal lymphoid infiltrates to malignant lymphoma 
in cutaneous pseudolymphoma is well delineated in the 
literature[23]. A potential association between lymphoma 
and PBC is suggested on the basis of  individual reports 
in the literature[24-29]. In a retrospective study by Panjala 
et al[30] based on an estimated 2,912 patients evaluated 
at their institution during a 22-year period, only 13 (an 
estimated 0.6%) patients were evaluated in referral visits 
for evidence of  lymphoma. Although we could find one 
case of  transformation of  hepatic pseudolymphoma into 
lymphoma[31], we were unable to deduce the long term 
natural course of  hepatic pseudolymphoma since most 
reported cases of  hepatic lymphoma underwent surgical 
resection.
In conclusion, we have reported a case of  hepatic 
pseudolymphoma associated with PBC. Hepatic pseudo-
lymphoma appears unique in its female preponderance 
and associated diseases. If  hypervascular nodules in the 
liver of  female patients with autoimmune disease are 
found, the possibility of  pseudolymphoma should be 
considered. Cases of  hepatic pseudolymphoma should 
be followed carefully as the exact nature of  this disorder 
is still not fully understood.
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